antibodies against the n-terminus of glua2 6c4 (Millipore)
Structured Review

Antibodies Against The N Terminus Of Glua2 6c4, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/glua2+n+terminus/glua1+antibody/pmc05073314-161-15-22
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "FAIM-L regulation of XIAP degradation modulates Synaptic Long-Term Depression and Axon Degeneration"
Article Title: FAIM-L regulation of XIAP degradation modulates Synaptic Long-Term Depression and Axon Degeneration
Journal: Scientific Reports
doi: 10.1038/srep35775
Figure Legend Snippet: Antibody-feeding internalization assay for endogenous GluA2 in hippocampal neurons stimulated with NMDA (50 μM for 15 min, ( B , D , F , H ). Neurons were previously infected with lentivirus containing with the shRNA vectors (scrambled – A , B , C , D – or XIAP – E , F , G , H –) and after 48 h were re-infected with either EMPTY-EGFP ( A , B , E , F ) or FAIM-L-EGFP ( C , D , G , H ) vectors, as indicated. The figure shows triple-label immunostaining for infected GFP-positive neurons (first and second column), surface-remaining GluA2 (third column, green in merge), internalized GluA2 (fourth column, red in merge), and merge (fifth column). Individual channels are shown in gray scale. Images in columns 2, 3, 4 and 5 represent magnifications from selected areas of the first columns. The scale bar represents 20 μm. ( I ) Shows quantitation of internalization index for the experiment represented in ( A–H ) integrated fluorescence intensity of internalized GluA2/integrated fluorescence intensity of surface-remaining GluA2. Results were not normalized to untreated cells (−NMDA) . As a consequence, A.U have no dimensions. N = 55 to 67 neurons from 3 independent experiments, for each group. Data represent mean ± SEM and and One-way ANOVA test followed by Tukey’s multiple comparison post-hoc test was used to calculate significant levels between the indicated groups. *p < 0.05; ***P < 0.001; ****p < 0.0001. ( J ) control experiment to demonstrate that the used XIAP-shRNA efficiently down-regulates the expression of its target protein. Hippocampal neurons were infected with lentivirus containing the scramble-shRNA vectors (upper panels) or XIAP-shRNA vectors (lower panels) and 72 h later they were fixed and immune-stained against XIAP. In lower panels, it can be clearly appreciated that only neurons infected with XIAP-shRNA showed a clear reduction of XIAP protein levels. However, the XIAP protein levels are not affected in non-infected neurons or neurons infected with scramble-shRNA.
Techniques Used: Infection, shRNA, Immunostaining, Quantitation Assay, Fluorescence, Comparison, Control, Expressing, Staining
Figure Legend Snippet: ( A – D ) antibody-feeding internalization assay for endogenous GluA2 in hippocampal neurons stimulated with NMDA (50 μM for 15 min). Neurons were infected with lentiviruses containing the shRNA constructs (scrambled or FAIM-L). The figure shows triple-label immunostaining for infected GFP-positive neurons (first and second column), surface-remaining GluA2 (third column, green in merge), internalized GluA2 (fourth column, red in merge), and merge (fifth column). Individual channels are shown in grayscale. Images in columns 2, 3, 4 and 5 represent magnifications from selected areas of the first columns. The scale bar represents 20 μm. ( E ) quantification of GluA2 internalization in the indicated conditions calculated as in . Results were not normalized to untreated cells (−NMDA). As a consequence, A.U have no dimensions. N = 48 to 53 neurons from 3 independent experiments, for each group. Data represent means ± SEM and were analyzed by the One-way ANOVA test followed by Newman-Keuls multiple comparison post-hoc test, ***p < 0.001, *p < 0.05.
Techniques Used: Infection, shRNA, Construct, Immunostaining, Comparison
Related Articles
Recombinant:Article Title: Article Snippet: The following commercial antibodies and reagents were used in this study: RIPK1 (Cell Signaling Technology, #3493); p-S166 RIPK1 (Biolynx Company, BX60008, mouse specific); MeCP2 (Cell Signaling Technology, #3456); β-actin (TransGen Biotech HC201); A20 (Cell Signaling Technology, #5630); Nox2 (ThermoFisher, PA5-76034); Nox1 (ThermoFisher, PA5-76034); SLC7A11 (Cell Signaling Technology, #12691); Mfn2 (Cell Signaling Technology, #11925); Drp1 (Cell Signaling Technology, #8570); p-S616 Drp1 (Cell Signaling Technology, #4494); PERK (Cell Signaling Technology, #3192); IRE1α (Cell Signaling Technology, #3294); ATF6 (Cell Signaling Technology, #65880); BiP (Abcam, ab21685); p-S51 eIF2α (Cell Signaling Technology, #3398); eIF2α (Cell Signaling Technology, #5324); VGLUT1 (Cell Signaling Technology, #47181); SNAT1 (Cell Signaling Technology, #36057); GLS1 (Cell Signaling Technology, #36057); GluA1 (Sigma-Aldrich, SAB5201086); GluA2/3 (MilliporeSigma, AB1506); anti-rabbit (SouthernBiotech, #4050-05); Iba1 (FUJIFILM, #019-19741); Iba1 (FUJIFILM, #011-27991); CD68 (Bio-Rad, MCA1957); mouseCD11b-APC (BioLegend, #101212); mouseCD45-488 (BioLegend, #103122); DAPI (ThermoFisher, D1306); anti-mouse (Southern Biotech, #1031-05); Recombinant hTNFα (Novoprotein, #C008); Article Title: Radixin in the nucleus accumbens core modulates amphetamine-induced locomotor activity based on context association. Article Snippet: A hallmark of drug addiction is pathological craving, or an urge for drugs of abuse (Cheron and Kerchove d’Exaerde 2021; Tiffany and Wray 2012), which increases the risk of relapse in people with substance use disorders (SUD) (Jaffe et al. 1989; Preston et al. 1993).. In rats, repeated exposure to psychostimulants, such as amphetamine (AMPH), leads to behavioral sensitization, manifested as an enhanced increase in locomotor activity when subsequently challenged with the drug following a withdrawal period.. Behavioral sensitization is largely mediated by increased dopamine transmission in the mesolimbic dopamine system, and has been proposed as an animal model that reflects characteristics observed in people with SUD, such as escalation of drug use and long-lasting craving (Boileau et al. 2006; Robinson and Berridge 1993; Vezina 2004). Article Title: Loss of SynDIG4/PRRT1 alters distribution of AMPA receptors in Rab4- and Rab11-positive endosomes and impairs basal AMPA receptor recycling Article Snippet: The primary antibodies included Article Title: A toolbox for ablating excitatory and inhibitory synapses Article Snippet: Primary antibody concentrations used: mouse anti- PSD- 95 (1:3000, Novus Biological, cat. # NB300- 556), Article Title: Combinatorial transcriptional regulation establishes subtype-appropriate synaptic properties in auditory neurons. Article Snippet: Cochlear turns were stained overnight with anti-Calb2 (1:1000, Swant CG1), anti-CTBP2 (1:500, BD Transduction Laboratories, Clone 16) and Article Title: Beta-hydroxybutyrate counteracts the deleterious effects of a saturated high-fat diet on synaptic AMPAR receptors and cognitive performance. Article Snippet: The antibodies used were anti-rabbit p845 GluA1 antibody (ab109464), anti-rabbit GluA2 (ab133477), and anti-rabbit PSD95 (ab18258) obtained from Abcam; Article Title: Gating and noelin clustering of native Ca 2+ -permeable AMPA receptors. Article Snippet: This is a PDF file of a peer-reviewed paper that has been accepted for publication.. Although unedited, the content has been subjected to preliminary formatting.. Nature is providing this early version of the typeset paper as a service to our authors and readers. Article Title: A toolbox for ablating excitatory and inhibitory synapses Article Snippet: Antibody , Anti-GluA1 (rabbit polyclonal) , Commercially available. , Millipore Plasmid Preparation:Article Title: Article Snippet: The following commercial antibodies and reagents were used in this study: RIPK1 (Cell Signaling Technology, #3493); p-S166 RIPK1 (Biolynx Company, BX60008, mouse specific); MeCP2 (Cell Signaling Technology, #3456); β-actin (TransGen Biotech HC201); A20 (Cell Signaling Technology, #5630); Nox2 (ThermoFisher, PA5-76034); Nox1 (ThermoFisher, PA5-76034); SLC7A11 (Cell Signaling Technology, #12691); Mfn2 (Cell Signaling Technology, #11925); Drp1 (Cell Signaling Technology, #8570); p-S616 Drp1 (Cell Signaling Technology, #4494); PERK (Cell Signaling Technology, #3192); IRE1α (Cell Signaling Technology, #3294); ATF6 (Cell Signaling Technology, #65880); BiP (Abcam, ab21685); p-S51 eIF2α (Cell Signaling Technology, #3398); eIF2α (Cell Signaling Technology, #5324); VGLUT1 (Cell Signaling Technology, #47181); SNAT1 (Cell Signaling Technology, #36057); GLS1 (Cell Signaling Technology, #36057); GluA1 (Sigma-Aldrich, SAB5201086); GluA2/3 (MilliporeSigma, AB1506); anti-rabbit (SouthernBiotech, #4050-05); Iba1 (FUJIFILM, #019-19741); Iba1 (FUJIFILM, #011-27991); CD68 (Bio-Rad, MCA1957); mouseCD11b-APC (BioLegend, #101212); mouseCD45-488 (BioLegend, #103122); DAPI (ThermoFisher, D1306); anti-mouse (Southern Biotech, #1031-05); Recombinant hTNFα (Novoprotein, #C008); Article Title: Radixin in the nucleus accumbens core modulates amphetamine-induced locomotor activity based on context association. Article Snippet: A hallmark of drug addiction is pathological craving, or an urge for drugs of abuse (Cheron and Kerchove d’Exaerde 2021; Tiffany and Wray 2012), which increases the risk of relapse in people with substance use disorders (SUD) (Jaffe et al. 1989; Preston et al. 1993).. In rats, repeated exposure to psychostimulants, such as amphetamine (AMPH), leads to behavioral sensitization, manifested as an enhanced increase in locomotor activity when subsequently challenged with the drug following a withdrawal period.. Behavioral sensitization is largely mediated by increased dopamine transmission in the mesolimbic dopamine system, and has been proposed as an animal model that reflects characteristics observed in people with SUD, such as escalation of drug use and long-lasting craving (Boileau et al. 2006; Robinson and Berridge 1993; Vezina 2004). Article Title: Loss of SynDIG4/PRRT1 alters distribution of AMPA receptors in Rab4- and Rab11-positive endosomes and impairs basal AMPA receptor recycling Article Snippet: The primary antibodies included Article Title: A toolbox for ablating excitatory and inhibitory synapses Article Snippet: Primary antibody concentrations used: mouse anti- PSD- 95 (1:3000, Novus Biological, cat. # NB300- 556), Article Title: Combinatorial transcriptional regulation establishes subtype-appropriate synaptic properties in auditory neurons. Article Snippet: Cochlear turns were stained overnight with anti-Calb2 (1:1000, Swant CG1), anti-CTBP2 (1:500, BD Transduction Laboratories, Clone 16) and Article Title: Beta-hydroxybutyrate counteracts the deleterious effects of a saturated high-fat diet on synaptic AMPAR receptors and cognitive performance. Article Snippet: The antibodies used were anti-rabbit p845 GluA1 antibody (ab109464), anti-rabbit GluA2 (ab133477), and anti-rabbit PSD95 (ab18258) obtained from Abcam; Article Title: Gating and noelin clustering of native Ca 2+ -permeable AMPA receptors. Article Snippet: This is a PDF file of a peer-reviewed paper that has been accepted for publication.. Although unedited, the content has been subjected to preliminary formatting.. Nature is providing this early version of the typeset paper as a service to our authors and readers. Article Title: A toolbox for ablating excitatory and inhibitory synapses Article Snippet: Antibody , Anti-GluA1 (rabbit polyclonal) , Commercially available. , Millipore Control:Article Title: Article Snippet: The following commercial antibodies and reagents were used in this study: RIPK1 (Cell Signaling Technology, #3493); p-S166 RIPK1 (Biolynx Company, BX60008, mouse specific); MeCP2 (Cell Signaling Technology, #3456); β-actin (TransGen Biotech HC201); A20 (Cell Signaling Technology, #5630); Nox2 (ThermoFisher, PA5-76034); Nox1 (ThermoFisher, PA5-76034); SLC7A11 (Cell Signaling Technology, #12691); Mfn2 (Cell Signaling Technology, #11925); Drp1 (Cell Signaling Technology, #8570); p-S616 Drp1 (Cell Signaling Technology, #4494); PERK (Cell Signaling Technology, #3192); IRE1α (Cell Signaling Technology, #3294); ATF6 (Cell Signaling Technology, #65880); BiP (Abcam, ab21685); p-S51 eIF2α (Cell Signaling Technology, #3398); eIF2α (Cell Signaling Technology, #5324); VGLUT1 (Cell Signaling Technology, #47181); SNAT1 (Cell Signaling Technology, #36057); GLS1 (Cell Signaling Technology, #36057); GluA1 (Sigma-Aldrich, SAB5201086); GluA2/3 (MilliporeSigma, AB1506); anti-rabbit (SouthernBiotech, #4050-05); Iba1 (FUJIFILM, #019-19741); Iba1 (FUJIFILM, #011-27991); CD68 (Bio-Rad, MCA1957); mouseCD11b-APC (BioLegend, #101212); mouseCD45-488 (BioLegend, #103122); DAPI (ThermoFisher, D1306); anti-mouse (Southern Biotech, #1031-05); Recombinant hTNFα (Novoprotein, #C008); Article Title: Radixin in the nucleus accumbens core modulates amphetamine-induced locomotor activity based on context association. Article Snippet: A hallmark of drug addiction is pathological craving, or an urge for drugs of abuse (Cheron and Kerchove d’Exaerde 2021; Tiffany and Wray 2012), which increases the risk of relapse in people with substance use disorders (SUD) (Jaffe et al. 1989; Preston et al. 1993).. In rats, repeated exposure to psychostimulants, such as amphetamine (AMPH), leads to behavioral sensitization, manifested as an enhanced increase in locomotor activity when subsequently challenged with the drug following a withdrawal period.. Behavioral sensitization is largely mediated by increased dopamine transmission in the mesolimbic dopamine system, and has been proposed as an animal model that reflects characteristics observed in people with SUD, such as escalation of drug use and long-lasting craving (Boileau et al. 2006; Robinson and Berridge 1993; Vezina 2004). Article Title: Loss of SynDIG4/PRRT1 alters distribution of AMPA receptors in Rab4- and Rab11-positive endosomes and impairs basal AMPA receptor recycling Article Snippet: The primary antibodies included Article Title: A toolbox for ablating excitatory and inhibitory synapses Article Snippet: Primary antibody concentrations used: mouse anti- PSD- 95 (1:3000, Novus Biological, cat. # NB300- 556), Article Title: Combinatorial transcriptional regulation establishes subtype-appropriate synaptic properties in auditory neurons. Article Snippet: Cochlear turns were stained overnight with anti-Calb2 (1:1000, Swant CG1), anti-CTBP2 (1:500, BD Transduction Laboratories, Clone 16) and Article Title: Beta-hydroxybutyrate counteracts the deleterious effects of a saturated high-fat diet on synaptic AMPAR receptors and cognitive performance. Article Snippet: The antibodies used were anti-rabbit p845 GluA1 antibody (ab109464), anti-rabbit GluA2 (ab133477), and anti-rabbit PSD95 (ab18258) obtained from Abcam; Article Title: Gating and noelin clustering of native Ca 2+ -permeable AMPA receptors. Article Snippet: This is a PDF file of a peer-reviewed paper that has been accepted for publication.. Although unedited, the content has been subjected to preliminary formatting.. Nature is providing this early version of the typeset paper as a service to our authors and readers. Article Title: A toolbox for ablating excitatory and inhibitory synapses Article Snippet: Antibody , Anti-GluA1 (rabbit polyclonal) , Commercially available. , Millipore |



